Catalyst Wire Dossier Catalyst Wire Dossier

XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS)

everolimus-eluting coronary stent · Abbott Medical Devices
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS), covering 2019-04-01 to 2019-04-01. Get the full timeline:

Most recent: Clinical Trial Update: XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study

See pricing